NCT07336030

Brief Summary

This study is conducted to assess baduanjin exercise for its ability to reduce cortisol levels in type 2 diabetic patients which in turn contributes to lowering blood glucose levels. the potential improvement in blood sugar levels can positively affect patients' quality of life and improving activities of daily living by reducing complications and dependance on medications , so baduanjin exercise supports the concept of health sustainability and enhancing long term wellbeing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 13, 2026

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

March 18, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

January 2, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

baduanjin exercisediabetes mellitus

Outcome Measures

Primary Outcomes (1)

  • Diabetes quality of life questionnaire

    diabetes quality of life questionnaire is used for assessing the patient's current condition and for evaluating improvements in quality of life following interventions. Higher score indicates bad quality of life

    12 weeks

Secondary Outcomes (3)

  • HbA1C

    12 weeks

  • functional capacity

    12 weeks

  • Katz index

    12 weeks

Study Arms (2)

Baduanjin group

EXPERIMENTAL

baduanjin exercise, diaphragmatic breathing and upper and lower limb stretching exercises

Other: baduanjin exercise

Breathing and stretching group

ACTIVE COMPARATOR

diaphragmatic breathing and upper and lower limb stretching exercises

Other: diaphragmatic breathing exercise and upper and lower limb stretching exercise

Interventions

baduanjin exercise is a type of traditional Chinese exercises that combines exercise and mindful breathing. Baduanjin also called eight section brocades Qigong, the combination of physical movement and intention in these exercises creates enjoyable experiences for both the body and the mind.

Baduanjin group

diaphragmatic breathing exercise is a breathing exercise which focuses on diaphragm muscle as it is the main respiratory muscle. While upper and lower stretching exercises focuses on flexibility and stretching of major muscle compartments of upper and lower limbs.

Breathing and stretching group

Eligibility Criteria

Age50 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients from both sexes diagnosed with type 2 diabetes.
  • Patients with type 2 diabetes for 5-10 years.
  • Patients are on oral antihyperglycemic drugs.
  • Patients with HbA1c levels between 6.5% and 7%
  • Age ranges from 50 to 60 years.
  • Patients with BMI from 30-34.9 kg/m2.

You may not qualify if:

  • patients with cardiac problems e.g. heart failure.
  • psychological or mental illness.
  • musculoskeletal problems.
  • neurological problems.
  • liver, kidney, lung diseases.
  • autoimmune diseases.
  • patients with cognitive diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of physical therapy, Cairo university

Giza, Egypt

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Demonstrator

Study Record Dates

First Submitted

January 2, 2026

First Posted

January 13, 2026

Study Start

September 30, 2025

Primary Completion

February 1, 2026

Study Completion

February 28, 2026

Last Updated

March 18, 2026

Record last verified: 2026-01

Locations